Common Triple Agonist Mistakes: Retatrutide Dosing Errors
The “triple agonist” molecule retatrutide is currently one of the most talked-about subjects in medical weight loss science. While it holds the promise of significant results, its potency also means that the margin for error is much smaller. As we move through 2026, doctors watching retatrutide are seeing a rise in triple agonist mistakes-often driven…


